Cite

    Rodriguez, C. et al. (n.d.). 286 Phase 2 proof-of-concept trial in progress—lirentelimab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments. British journal of dermatology. p. . [Online].